肱骨头非创伤性缺血性坏死治疗中半肩关节置换与全肩关节置换四年假体生存率比较
基于荷兰关节置换登记系统(LROI)2014年1月至2023年1月间280例肱骨头非创伤性缺血性坏死肩关节(159例初次半肩置换、121例全肩置换),随访四年内半肩置换翻修7例(4%)、全肩置换翻修8例(7%),差异无统计学意义(p=0.523);半肩与全肩累积翻修率分别为6%和8%(HR 1.1,95%CI 0.5至2.7)。结论认为在无显著盂磨损的肱骨头非创伤性缺血性坏死患者中,半肩置换与全肩置换短期至中期假体生存率无显著差异。
要点
- 随访四年内半肩置换翻修7例(4%),全肩置换翻修8例(7%),差异无统计学意义(p=0.523)。
- 半肩与全肩累积翻修率分别为6%和8%(HR 1.1,95%CI 0.5至2.7)。
- 半肩翻修中2例因进行性盂侵蚀,全肩翻修中3例因盂组件松动。
核心结论
- 在无显著盂磨损的肱骨头非创伤性缺血性坏死患者中,半肩置换与全肩置换的短期至中期假体生存率无显著差异。
研究设计与样本
- 基于荷兰关节置换登记系统(LROI)2014年1月至2023年1月的数据,纳入280例肱骨头非创伤性缺血性坏死肩关节,其中初次半肩置换159例、全肩置换121例,采用Kaplan-Meier生存分析和Cox回归分析。
主要发现
- 随访四年内共15例翻修,半肩置换7例(4%),全肩置换8例(7%),差异无统计学意义(p=0.523)。
- 半肩置换翻修中2例因进行性盂侵蚀,全肩置换翻修中3例因盂组件松动。
- 半肩置换与全肩置换的累积翻修率分别为6%和8%(HR 1.1,95%CI 0.5至2.7)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Hemiarthroplasty (HA) and total shoulder arthroplasty (TSA) are often the preferred forms of treatment for patients with atraumatic avascular necrosis of the humeral head when conservative treatment fails. Little has been reported about the survival of HA and TSA for this indication. The aim of this study was to investigate the differences in revision rates between HA and TSA in these patients, to determine whether one of these implants has a superior survival and may be a better choice in the treatment of this condition. METHODS: Data from 280 shoulders with 159 primary HAs and 121 TSAs, which were undertaken in patients with atraumatic avascular necrosis of the humeral head between January 2014 and January 2023 from the Dutch Arthroplasty Register (LROI), were included. Kaplan-Meier survival analysis and Cox regression analysis were undertaken. RESULTS: Within four years of follow-up, a total of 15 revisions were required, involving seven HAs (4%) and eight TSAs (7%). This difference was not statistically significant (p = 0.523). Two HAs were revised because of progressive glenoid erosion, and three TSAs were revised for loosening of the glenoid component. The cumulative percentages of revision of HA and TSA were 6% and 8%, respectively (HR 1.1 (95% CI 0.5 to 2.7)). CONCLUSION: We found no significant difference in short- to mid-term implant survival between the use of a HA and a TSA in the treatment of atraumatic avascular necrosis of the humeral head, without significant glenoid wear.
引用
- Smeitink N, Schröder FF, Dorrestijn O, et al. Implant survival at four years for hemiarthroplasty and total shoulder arthroplasty in the treatment of atraumatic avascular necrosis of the humeral head. Bone Joint J. 2025. PMID: 39740679. doi:10.1302/0301-620X.107B1.BJJ-2024-0459.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。